Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $391,673 - $469,942
-4,100 Reduced 26.16%
11,574 $1.09 Million
Q2 2023

Jul 28, 2023

SELL
$100.78 - $112.29 $554,290 - $617,595
-5,500 Reduced 25.98%
15,674 $1.71 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $493,986 - $581,451
-5,100 Reduced 19.41%
21,174 $2.14 Million
Q1 2022

Apr 22, 2022

BUY
$114.02 - $139.04 $133,859 - $163,232
1,174 Added 4.68%
26,274 $3.11 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $5,776 - $7,073
-50 Reduced 0.2%
25,100 $3.53 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $52,895 - $62,265
-500 Reduced 1.95%
25,150 $2.92 Million
Q4 2019

Jan 09, 2020

SELL
$78.51 - $87.4 $47,106 - $52,440
-600 Reduced 2.29%
25,650 $2.23 Million
Q3 2018

Oct 16, 2018

SELL
$60.81 - $73.36 $310,131 - $374,136
-5,100 Reduced 16.27%
26,250 $1.93 Million
Q3 2018

Oct 12, 2018

BUY
$60.81 - $73.36 $310,131 - $374,136
5,100 Added 19.43%
31,350 $1.67 Million
Q4 2017

Jan 12, 2018

SELL
$53.68 - $57.47 $273,768 - $293,097
-5,100 Reduced 16.27%
26,250 $1.5 Million
Q3 2017

Oct 18, 2017

BUY
$48.06 - $53.64 $1.51 Million - $1.68 Million
31,350
31,350 $1.67 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Private Capital Advisors, Inc. Portfolio

Follow Private Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Advisors, Inc. with notifications on news.